Effect of GABAergic drugs on dopamine catabolism in the nigrostriatal and mesolimbic dopaminergic pathways of the rat.
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors; D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D018756:GABA Antagonists; D008032:Limbic System / Q000378:metabolism*; D008297:Male; D010852:Picrotoxin / Q000494:pharmacology; D051381:Rats; D011956:Receptors, Cell Surface / Q000502:physiology; D011954:Receptors, Dopamine / Q000187:drug effects*; D011963:Receptors, GABA-A; D013378:Substantia Nigra / Q000378:metabolism*; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology*
D000612:4-Aminobutyrate Transaminase; D004298:Dopamine; D018756:GABA Antagonists; D010852:Picrotoxin; D011956:Receptors, Cell Surface; D011954:Receptors, Dopamine; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid